-
Original Article
-
Korean J Med. 2009;76(2):137-142.
- 골수이형성증의 NCCN 치료지침과 최적의 보조요법
-
최철원
-
- The NCCN clinical practice guidelines and best supportive care for the myelodysplastic syndromes
-
Chul Won Choi
-
-
- Abstract
- The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem-cell disorders
characterized by peripheral cytopenias and hypercellular, dysplastic bone marrow. Appropriate treatment of cytopenia, as
well as of other related complications, affect the overall survival of patients. The best supportive care including red blood
cell or platelet transfusions and antibiotics have been the most frequent treatment given for patients with MDS.
Now new drugs have recently been approved for treating specific subtypes of MDS. Because the choice of therapy and
the decision to begin treatment must be tailored to each patient, specific practice guidelines based on extensive evaluation
of the data are warranted for both patients and treating physicians. Here, the National Comprehensive Cancer Network
(NCCN) clinical practice guidelines for the MDS and currently available options for the best supportive care have been
reviewed. (Korean J Med 76:137-142, 2009)
Keywords :Myelodysplastic syndromes, Practice guideline
